Clinical Trial Update: High Dose Vitamin C in the Critically Ill Patient [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose vitamin C in critically ill patients with shock has been terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shock

Drugs mentioned

• Vitamin C (ascorbic acid)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Shock | Phase 2 | Status: TERMINATED | Results posted: 2017-05-11